Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
Matteo Ponzo(Centre National de la Recherche Scientifique), Ilaria Cascone(Inserm), Anaïs Debesset(Inserm), José L. Cohen(Inserm), Philippe Bouvet(Université Claude Bernard Lyon 1), Serena Brundu(Candiolo Cancer Institute), Fabio Raineri(Inserm), Christophe Tournigand(Université Paris-Est Créteil), Rémy Nicolle(Centre National de la Recherche Scientifique), Federica Maione(University of Turin), Allan Thiolat(Inserm), Alba Nicolás‐Boluda(Unknown), Caroline Pilon(Inserm), José Courty(Université Claude Bernard Lyon 1), Florence Gazeau(Centre National de la Recherche Scientifique), Carina F. Cojocaru(Candiolo Cancer Institute), Corinne Bousquet(Centre National de la Recherche Scientifique), Mélissande Cossutta(Centre National de la Recherche Scientifique), Enrico Giraudo(University of California, San Francisco), Mounira Chalabi‐Dchar(Inserm), Sylvain Meunier(Inserm), Claire Houppe(Inserm)
Cited by 0
Related Papers
Potential of fecal microbiota for early‐stage detection of colorectal cancer
|Molecular Systems Biology|2014|1.4k
An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis
|Journal of Clinical Investigation|2004|609
An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis
|Journal of Clinical Investigation|2004|576
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390